BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12678165)

  • 1. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
    Thong-Ngam D; Thumvijit L; Tangkijvanich P; Janchai A; Mahachai V; Wittayalertpanya S
    J Med Assoc Thai; 2002 Dec; 85(12):1280-7. PubMed ID: 12678165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
    Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
    Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization.
    Liu CL; Ngan H; Lo CM; Fan ST
    Br J Surg; 1998 Apr; 85(4):512-4. PubMed ID: 9607536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma.
    Haider Z; ul Haq T; Munir K; Usman MU; Azeemuddin M
    J Coll Physicians Surg Pak; 2006 Apr; 16(4):265-9. PubMed ID: 16624189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
    Hasan I; Wickenhöfer R; Görich J; Hartlapp JH; Reiser M
    Dtsch Med Wochenschr; 1992 Apr; 117(15):576-80. PubMed ID: 1373113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous cryoablation after chemoembolization of liver carcinoma: report of 34 cases.
    Qian GJ; Chen H; Wu MC
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):520-4. PubMed ID: 14627512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma].
    Zhou ZJ; Xu RD; Li WK; Zhuang WX; Lu LG; Shao PJ; Chen XM; Luo PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1866-8. PubMed ID: 18159005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
    Chen M; Li J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy.
    Wittayalertpanya S; Mahachai V
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S189-96. PubMed ID: 11529334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.
    Sasaki A; Kai S; Iwashita Y; Hirano S; Ohta M; Kitano S
    Cancer; 2005 Jan; 103(2):299-306. PubMed ID: 15578688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.